Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Lymphocytic, Chronic, B-Cell × Taxes × 90 days × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 14 Ovarian Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Fallopian Tube Neoplasms 10 Neoplasm Metastasis 9 Lung Neoplasms 7 Endometrial Neoplasms 7 Breast Neoplasms 6 Triple Negative Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Oropharyngeal Neoplasms 3 Mouth Neoplasms 3 Laryngeal Neoplasms 3 Hypopharyngeal Neoplasms 3 Carcinoma 3 Neoplasms 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Transitional Cell 2 Carcinoma, Squamous Cell 2 Brenner Tumor 2 Anatomic Stage II Breast Cancer AJCC v8 2 Adenocarcinoma of Lung 2 Adenocarcinoma Of Esophagus 2 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Stomach Neoplasms 1 Sinonasal Squamous Cell Carcinoma 1

Interventions

venetoclax 42 Rituximab 25 obinutuzumab 22 ibrutinib 22 Cyclophosphamide 22 acalabrutinib 19 pirtobrutinib 17 fludarabine 17 Specimen Handling 11 zanubrutinib 10 fludarabine phosphate 10 Biopsy 10 Bendamustine Hydrochloride 10 Magnetic Resonance Spectroscopy 7 Whole-Body Irradiation 5 Prednisone 5 Lenalidomide 5 idelalisib 4 Vincristine 4 Mycophenolic Acid 4 Doxorubicin 4 CT-P10 4 ARQ531 4 pembrolizumab 3 Tacrolimus 3 tocilizumab 2 duvelisib 2 daratumumab 2 atezolizumab 2 Therapeutics 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡